A 3T MR Imaging Investigation of the Topography of Whole Spinal Cord Atrophy in Multiple Sclerosis

References

1. 1.↵
   1. Bermel RA,
   2. Bakshi R

   . The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5: 158– 70

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Lin X,
   2. Tench CR,
   3. Evangelou N,
   4. et al

   . Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging 2004; 14: 20S–26S

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Lublin FD,
   2. Reingold SC

   . Defining the clinical course of multiple sclerosis: results of an international survey—National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907– 11

   Abstract/FREE Full Text
4. 4.↵
   1. Evangelou N,
   2. DeLuca GC,
   3. Owens T,
   4. et al

   . Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 2005; 128: 29– 34

   Abstract/FREE Full Text
5. 5.↵
   1. Gilmore CP,
   2. DeLuca GC,
   3. Bö L,
   4. et al

   . Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol 2009; 19: 642– 49

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Tallantyre EC,
   2. Bo L,
   3. Al-Rawashdeh O,
   4. et al

   . Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 2009; 132: 1190– 99

   Abstract/FREE Full Text
7. 7.↵
   1. Gilmore CP,
   2. Bo L,
   3. Owens T,
   4. et al

   . Spinal cord gray matter demyelination in multiple sclerosis: a novel pattern of residual plaque morphology. Brain Pathol 2006; 16: 202– 08

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Lycklama à Nijeholt GJ,
   2. Barkhof F,
   3. et al

   . MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 1997; 18: 1041– 48

   Abstract
9. 9.↵
   1. Lin X,
   2. Blumhardt LD,
   3. Constantinescu CS

   . The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study. Acta Neurol Scand 2003; 108: 401– 06

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Horsfield MA,
    2. Sala S,
    3. Neema M,
    4. et al

    . Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage 2010; 50: 446– 55

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Filippi M,
    2. Bozzali M,
    3. Horsfield MA,
    4. et al

    . A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 2000; 54: 207– 13

    Abstract/FREE Full Text
12. 12.↵
    1. Liu C,
    2. Playford ED,
    3. Thompson AJ

    . Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 2003; 250: 1214– 18

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Bieniek M,
    2. Altmann DR,
    3. Davies GR,
    4. et al

    . Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 1036– 39

    Abstract/FREE Full Text
14. 14.↵
    1. Zivadinov R,
    2. Banas AC,
    3. Yella V,
    4. et al

    . Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol 2008; 29: 319– 25

    Abstract/FREE Full Text
15. 15.↵
    1. Rashid W,
    2. Davies GR,
    3. Chard DT,
    4. et al

    . Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006; 77: 51– 55

    Abstract/FREE Full Text
16. 16.↵
    1. Mann RS,
    2. Constantinescu CS,
    3. Tench CR

    . Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross-sectional area on magnetic resonance images. J Magn Reson Imaging 2007; 26: 61– 65

    CrossRefPubMed
17. 17.↵
    1. Gilmore CP,
    2. DeLuca GC,
    3. Bo L,
    4. et al

    . Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol 2005; 62: 1859– 62

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Stankiewicz JM,
    2. Neema M,
    3. Alsop DC,
    4. et al

    . Spinal cord lesions and clinical status in multiple sclerosis: a 1.5 T and 3 T MRI study. J Neurol Sci 2009; 279: 99– 105

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Arora A,
    2. Neema M,
    3. Stankiewicz J,
    4. et al

    . Regional and whole spinal cord atrophy in multiple sclerosis. Annual Meeting of the American Academy of Neurology, Chicago, Illinois. Neurology 2008; 70 (Suppl 1): A464

    CrossRef
20. 20.↵
    1. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444– 52

    Abstract/FREE Full Text
21. 21.↵
    1. Cohen AB,
    2. Neema M,
    3. Arora A,
    4. et al

    . The relationship between spinal cord atrophy, brain atrophy, and disability in multiple sclerosis. Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada. Neurology 2010; 74 (Suppl 2): A236
22. 22.↵
    1. Deichmann R,
    2. Schwarzbauer C,
    3. Turner R

    . Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. Neuroimage 2004; 21: 757– 67

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Tardif CL,
    2. Collins DL,
    3. Pike GB

    . Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3 T. Neuroimage 2009; 44: 827– 38

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Arora A,
    2. Neema M,
    3. Tauhid S,
    4. et al

    . Global vs. regional spinal cord atrophy in multiple sclerosis. Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada. Neurology 2010; 74 (Suppl 2): A118
25. 25.↵
    1. Holm S

    . A simple sequentially rejective multiple test procedure. Scand J Statistics 1979; 6: 65– 70

    Web of Science
26. 26.↵
    1. Rashid W,
    2. Davies GR,
    3. Chard DT,
    4. et al

    . Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J Magn Reson Imaging 2006; 23: 473– 76

    CrossRefPubMed
27. 27.↵
    1. Dalton CM,
    2. Chard DT,
    3. Davies GR,
    4. et al

    . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101– 07

    Abstract/FREE Full Text
28. 28.↵
    1. Zivadinov R,
    2. Reder AT,
    3. Filippi M,
    4. et al

    . Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 2008; 71: 136– 44

    Abstract/FREE Full Text
29. 29.↵
    1. Miller DH

    . Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004; 1: 284– 94

    Abstract/FREE Full Text
30. 30.↵
    1. Zivadinov R,
    2. Bakshi R

    . Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci 2004; 9: 665– 83

    PubMedWeb of Science
31. 31.↵
    1. Zivadinov R,
    2. Leist TP

    . Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 2005; 15: 10S–21S

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Marliani AF,
    2. Clementi V,
    3. Albini Riccioli L,
    4. et al

    . Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 2010; 31: 180– 84

    Abstract/FREE Full Text